Figure 13 represents three different groups and the comparative changes in histology (Figure 13A,B). The lipid accumulation within the hepatic cells was reduced in the PASM group (Figure 13E) as compared to the PA (Figure 13C). In the PPAR-α antagonist group macrovesicular steatosis can be observed with scattered and distant hepatocytes. The regain of morphology may be due to the efficacy of synbiotic (Figure 13D,E) as a therapeutic agent that can help in lipolysis process through the bioactive compounds present in the AGE. This evidence concerns the gene PPARA and steatosis.